Professor Vlado Perkovic

拓展阅读

• Professor Bruce Neal appointed Executive Director of The George Institute Australia

  29/08/2019

  

• Standalone grabs with Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial

  

• Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial

  

• Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial (with subtitles)

  

• New breakthrough treatment for kidney disease offers hope for hundreds of millions of people with diabetes worldwide

  15/04/2019

  

• Response by The George Institute, Australia – Budget 2019-20

  03/04/2019

  

• Close the Gap 2019 Report: The George Institute statement

  26/03/2019

  

• The George Institute’s response to the 2019 NSW election

  26/03/2019

  

• 1.4 million people die every year in India because they cannot afford dialysis

  

• Randomised Evaluation of Sodium Dialysate Levels on Vascular Events (RESOLVE)

  

• Potential breakthrough treatment for chronic kidney disease and diabetes

  17/07/2018

  

• George Institute’s Vlado Perkovic joins NEJM editorial board

  08/11/2017

  

• Latest NHMRC grants a boost in the fight against chronic disease and injury

  12/10/2017

  

• World's first affordable dialysis machine a finalist in the Eureka Awards

  30/09/2017

  

• High risk of infection with steroid treatment for people with kidney disease

  02/08/2017

  

• World’s first affordable dialysis machine a finalist in 2017 Eureka Awards

  28/07/2017

  

• 'A vision for creating a healthy Australia' with Martin Bowles PSM, Secretary, Department of Health

  27/07/2017

  

• New era in type 2 diabetes treatment: CANVAS study results available

  13/06/2017

  

• UNSW Sydney and The George Institute affiliation marks new era in Australian health research

  26/05/2017

  

• The affordable dialysis project

• 2017 Clinical Trial Awards announced: The George Institute a double finalist

  22/05/2017

  

• New MRFF funding for clinical trials will save lives

  19/05/2017

  

• Making sure all Australians have access to the care they need: response to Australia's Federal Budget

  10/05/2017

  

• "We welcome the targeted investment in research and health system initiatives": response to Australia's Federal Budget

  09/05/2017

  

• Response to the proposed changes to Australia’s 457 visa

  21/04/2017

  

• Response to the Medical Research Future Fund strategy and priorities

  09/11/2016

  

• The George Institute's new AAHMS fellows

  07/10/2016

  

• New report calls for fresh approach to treating the world’s No. 1 killer

  27/09/2016

  

• The George Institute welcomes appointment of Ms Frances Adamson as new DFAT Secretary

  22/07/2016

  

• Welcoming the reappointment of Minister Ley and new Turnbull Ministry

  19/07/2016

  

• New hypertension guidelines released

  18/07/2016

  

• Response to Federal election results on 2 July 2016

  12/07/2016

  

• The George Institute supports Australia's first national health card

  05/07/2016

  

• The Medical Research Future Fund is key to delivering a healthier Australia

  09/06/2016

  

• The George Institute supports the Prevention 1st Alliance and greater investment in prevention

  03/06/2016

  

• Steroids help preserve kidney function, but at a cost, says major new global study

  23/05/2016

  

• World’s first low cost dialysis unveiled

  10/03/2016

  

• Prof Vlado Perkovic: Shaping healthcare around the world

  27/01/2016

  

• Blood pressure lowering keeps even more Australians alive longer

  10/11/2015

  

• Servier invests in Australian researchers

  26/10/2015

  

• Now is the time to invest in healthier lives

  12/08/2015

  

• Therapeutic Evaluation of STeroids in IgA Nephropathy Global study (TESTING)

  

• Extended dialysis makes little difference

  16/11/2014

  

• Simple screening test greatly improves heart attack prediction for diabetics

  17/01/2014

  

• Fibrates reduce CV risk in patients with CKD

  

• Vlado Perkovic appointed as new Executive Director, Australia

  07/02/2012

  

• Action in Diabetes and Vascular disease Preterax and Diamicron-MR Controlled Evaluation Biomarker Studies (ADVANCE-Biomarker)

  

• ACTIVE Dialysis - A clinical trial of intensive dialysis

  

• Renal and metabolic